Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn

Overview

Journal Stem Cells Transl Med

Publisher Oxford University Press

Specialties Cell Biology
Pharmacology

Date 2022 Apr 29

PMID 35485440

Authors

Kirat Chand

Rachel Nano

Julie Wixey

Jatin Patel

Affiliations

Soon will be listed here.

Abstract

Fetal growth restriction (FGR) occurs when a fetus is unable to grow normally due to inadequate nutrient and oxygen supply from the placenta. Children born with FGR are at high risk of lifelong adverse neurodevelopmental outcomes, such as cerebral palsy, behavioral issues, and learning and attention difficulties. Unfortunately, there is no treatment to protect the FGR newborn from these adverse neurological outcomes. Chronic inflammation and vascular disruption are prevalent in the brains of FGR neonates and therefore targeted treatments may be key to neuroprotection. Tissue repair and regeneration via stem cell therapies have emerged as a potential clinical intervention for FGR babies at risk for neurological impairment and long-term disability. This review discusses the advancement of research into stem cell therapy for treating neurological diseases and how this may be extended for use in the FGR newborn. Leading preclinical studies using stem cell therapies in FGR animal models will be highlighted and the near-term steps that need to be taken for the development of future clinical trials.

Citing Articles

The brain of fetuses with congenital diaphragmatic hernia shows signs of hypoxic injury with loss of progenitor cells, neurons, and oligodendrocytes.

Biouss G, Antounians L, Aguet J, Kopcalic K, Fakhari N, Baranger J Sci Rep. 2024; 14(1):13680.

PMID: 38871804 PMC: 11176194. DOI: 10.1038/s41598-024-64412-x.

Anti-inflammatory effects of antenatal administration of stem cell derived extracellular vesicles in the brain of rat fetuses with congenital diaphragmatic hernia.

Blundell M, Doktor F, Figueira R, Khalaj K, Biouss G, Antounians L Pediatr Surg Int. 2023; 39(1):291.

PMID: 37955723 DOI: 10.1007/s00383-023-05578-9.

Effects of fetal growth restriction on the perinatal neurovascular unit and possible treatment targets.

Wu B, Chand K, Bell A, Miller S, Colditz P, Malhotra A Pediatr Res. 2023; 95(1):59-69.

PMID: 37674023 PMC: 10798895. DOI: 10.1038/s41390-023-02805-w.

Do Extracellular Vesicles Derived from Mesenchymal Stem Cells Contain Functional Mitochondria?.

Zorova L, Kovalchuk S, Popkov V, Chernikov V, Zharikova A, Khutornenko A Int J Mol Sci. 2022; 23(13).

PMID: 35806411 PMC: 9266972. DOI: 10.3390/ijms23137408.

References

Chand K, Patel J, Bjorkman S, Sim S, Miller S, Teo E . Combination of human endothelial colony-forming cells and mesenchymal stromal cells exert neuroprotective effects in the growth-restricted newborn. NPJ Regen Med. 2021; 6(1):75. PMC: 8602245. DOI: 10.1038/s41536-021-00185-5. View

Mallard C, Ek C, Vexler Z . The myth of the immature barrier systems in the developing brain: role in perinatal brain injury. J Physiol. 2018; 596(23):5655-5664. PMC: 6265562. DOI: 10.1113/JP274938. View

Hofstetter C, Schwarz E, Hess D, Widenfalk J, El Manira A, Prockop D . Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A. 2002; 99(4):2199-204. PMC: 122342. DOI: 10.1073/pnas.042678299. View

Nabetani M, Shintaku H, Hamazaki T . Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy. Pediatr Res. 2017; 83(1-2):356-363. DOI: 10.1038/pr.2017.260. View

Kalanjati V, Wixey J, Miller S, Colditz P, Bjorkman S . GABA receptor expression and white matter disruption in intrauterine growth restricted piglets. Int J Dev Neurosci. 2017; 59:1-9. DOI: 10.1016/j.ijdevneu.2017.02.004. View

Hsuan Y, Lin C, Chang C, Lin M . Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke. Brain Behav. 2016; 6(10):e00526. PMC: 5064338. DOI: 10.1002/brb3.526. View

Ullah I, Subbarao R, Rho G . Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015; 35(2). PMC: 4413017. DOI: 10.1042/BSR20150025. View

Poudel R, McMillen I, Dunn S, Zhang S, Morrison J . Impact of chronic hypoxemia on blood flow to the brain, heart, and adrenal gland in the late-gestation IUGR sheep fetus. Am J Physiol Regul Integr Comp Physiol. 2014; 308(3):R151-62. DOI: 10.1152/ajpregu.00036.2014. View

Sovio U, White I, Dacey A, Pasupathy D, Smith G . Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet. 2015; 386(10008):2089-2097. PMC: 4655320. DOI: 10.1016/S0140-6736(15)00131-2. View

10.

van Velthoven C, Kavelaars A, van Bel F, Heijnen C . Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun. 2009; 24(3):387-93. DOI: 10.1016/j.bbi.2009.10.017. View

11.

Schanzer A, Wachs F, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H . Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 2004; 14(3):237-48. PMC: 8096047. DOI: 10.1111/j.1750-3639.2004.tb00060.x. View

12.

Cheng Q, Zhang Z, Zhang S, Yang H, Zhang X, Pan J . Human umbilical cord mesenchymal stem cells protect against ischemic brain injury in mouse by regulating peripheral immunoinflammation. Brain Res. 2014; 1594:293-304. DOI: 10.1016/j.brainres.2014.10.065. View

13.

Rouhl R, van Oostenbrugge R, Damoiseaux J, Cohen Tervaert J, Lodder J . Endothelial progenitor cell research in stroke: a potential shift in pathophysiological and therapeutical concepts. Stroke. 2008; 39(7):2158-65. DOI: 10.1161/STROKEAHA.107.507251. View

14.

Vossbeck S, de Camargo O, Grab D, Bode H, Pohlandt F . Neonatal and neurodevelopmental outcome in infants born before 30 weeks of gestation with absent or reversed end-diastolic flow velocities in the umbilical artery. Eur J Pediatr. 2001; 160(2):128-34. DOI: 10.1007/s004310000680. View

15.

Kokaia Z, Martino G, Schwartz M, Lindvall O . Cross-talk between neural stem cells and immune cells: the key to better brain repair?. Nat Neurosci. 2012; 15(8):1078-87. DOI: 10.1038/nn.3163. View

16.

Wixey J, Chand K, Colditz P, Bjorkman S . Review: Neuroinflammation in intrauterine growth restriction. Placenta. 2016; 54:117-124. DOI: 10.1016/j.placenta.2016.11.012. View

17.

Arthurs O, Rega A, Guimiot F, Belarbi N, Rosenblatt J, Biran V . Diffusion-weighted magnetic resonance imaging of the fetal brain in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2016; 50(1):79-87. DOI: 10.1002/uog.17318. View

18.

Forostyak S, Jendelova P, Kapcalova M, Arboleda D, Sykova E . Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis. Cytotherapy. 2011; 13(9):1036-46. DOI: 10.3109/14653249.2011.592521. View

19.

McElrath T, Allred E, Van Marter L, Fichorova R, Leviton A . Perinatal systemic inflammatory responses of growth-restricted preterm newborns. Acta Paediatr. 2013; 102(10):e439-42. PMC: 3773878. DOI: 10.1111/apa.12339. View

20.

Penney J, Ralvenius W, Tsai L . Modeling Alzheimer's disease with iPSC-derived brain cells. Mol Psychiatry. 2019; 25(1):148-167. PMC: 6906186. DOI: 10.1038/s41380-019-0468-3. View